Loading clinical trials...
Loading clinical trials...
This First-in-Human (FIH) Phase 1/2 study will evaluate mRNA-3704 in patients with methylmalonic acidemia/aciduria (MMA) due to methylmalonyl-coenzyme A mutase (MUT) deficiency between 1 to 18 years o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ModernaTX, Inc.
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT05425745 · Dyslipidemias, High Cholesterol, and more
NCT05778877 · Methylmalonic Acidemia (MMA)
NCT00092898 · Lipid Metabolism, Inborn Errors, Heart Disease
NCT00092820 · Lipid Metabolism, Inborn Errors, Heart Disease
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions